Hint mode is switched on Switch off

Century Therapeutics, ordinary share
IPSC, US15673T1007

Add a stock to WL
Choose all Reset all
Century Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Century Therapeutics, Inc. operates as a biotech company. The Company specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides ...
Century Therapeutics, Inc. operates as a biotech company. The Company specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services. Century Therapeutics serves customers worldwide.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Century Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IPSC
  • Placement
    18.06.2021
  • Lock up period
    180
  • Number of papers
    10,550,000
  • Volume of raised funds
    211 mln USD
  • Placement share
    19.24%
  • Final placement price
    20 USD
  • Price change since placement date
    -89.35%
  • By capitalization
    1,096.49 mln USD

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

13/05/2026 Century Therapeutics: Results Of Operations And Financial Condition, Financial Statements And Exhibits
26/03/2026 Century Therapeutics: Other Events, Financial Statements And Exhibits
22/01/2026 Century Therapeutics: Submission Of Matters To A Vote Of Security Holders, Other Events
07/01/2026 Century Therapeutics: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits
12/12/2025 Century Therapeutics: Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.